mRNA Vaccine Production a Key Focus as CDMO Samsung Biologics Attends mRNA-Based Therapeutics Summit
July 26, 2022, marked the opening of the 2nd annual mRNA-Based Therapeutics Summit in Boston. The future of mRNA therapeutics has been an important topic of discussion and research within the biopharmaceutical industry following the successful use of COVID-19 mRNA vaccines, the first mRNA vaccines approved for human use. Samsung Biologics, leading contract development and